Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IBIO

iBio, Inc.

CIK 0001420720 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.43
↓ 0.04 (-2.72%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$71.04M
P/E Ratio
-2.57
EPS
-1.75
Dividend Yield
Not covered
52W Position
23%
Beta
2.09

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
0.92
P/S
177.60
EV/Revenue
58.52
ROE
-35.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 23%
$0.73$3.82

Latest Financials

2025-06-30 FY
Revenue
$400.00K
Net Income
-$18.38M
Total Assets
$23.18M
Free Cash Flow
-$15.32M

Recent news